NPM1 FLT3 CEBPA Test
Introduction
The NPM1 FLT3 CEBPA test is a sophisticated genetic test that plays a crucial role in the diagnosis and management of acute myeloid leukemia (AML). This test analyzes specific mutations in the NPM1, FLT3, and CEBPA genes, which are essential for understanding the genetic landscape of leukemia. By identifying these mutations, healthcare providers can tailor treatment strategies and improve patient outcomes.
What the Test Measures
This test detects mutations in three key genes:
- NPM1: Associated with a favorable prognosis in AML.
- FLT3: Often linked to poor outcomes and increased risk of relapse.
- CEBPA: Can indicate a better prognosis when mutated.
Who Should Consider This Test
The NPM1 FLT3 CEBPA test is recommended for individuals who:
- Are diagnosed with acute myeloid leukemia.
- Exhibit symptoms such as unexplained fatigue, frequent infections, or easy bruising.
- Have risk factors including a family history of blood disorders.
Benefits of Taking the Test
Understanding your genetic makeup through this test offers several benefits:
- Informs treatment decisions, allowing for personalized therapy.
- Helps predict prognosis and potential treatment outcomes.
- Guides monitoring for potential relapse.
Understanding Your Results
Results from the NPM1 FLT3 CEBPA test can provide critical insights into your health. Positive mutations may indicate a need for aggressive treatment, while negative results can suggest a more favorable prognosis. Always discuss your results with your healthcare provider to understand their implications fully.
Test Details and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
NPM1 FLT3 CEBPA | 390,000 NGN | 520,000 NGN |
How to Book the Test
To book the NPM1 FLT3 CEBPA test, please call or WhatsApp us at +2348077798758. Ensure you have a doctor’s prescription, as it is required for testing. Note that prescriptions are not applicable for surgery and pregnancy cases or individuals planning to travel abroad. Turnaround time for results is approximately 7-8 days.
Sample Collection
The test requires a sample of either bone marrow or peripheral blood, which should be transported immediately to ensure the integrity of the results.
Pre-Test Instructions
Before undergoing the NPM1 FLT3 CEBPA test, consult with your healthcare provider to ensure that you meet the necessary criteria for testing.